WELIREG 40 mg/1 (Belzutifan TABLET, FILM COATED) 40 mg/1

WELIREG 40 mg is a film-coated tablet containing belzutifan, used for specific medical conditions. This oral medication is manufactured by Merck Sharp & Dohme LLC in the USA.

Strength

40 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0006-5331-59) / 90 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

WELIREG 40 mg is primarily used to address certain medical conditions related to cellular processes. Belzutifan, the active ingredient, is often prescribed for conditions that involve abnormal cell growth. Patients may wonder, 'What is WELIREG used for?' Typically, it is utilized in scenarios where targeted therapy is required to manage specific health issues.

Side Effects

Common effects of WELIREG 40 mg may include fatigue, nausea, and dizziness. Some users might experience changes in blood pressure or anemia. It's important to monitor these effects and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

WELIREG 40 mg should be handled with care, especially by individuals with pre-existing conditions like anemia or hypertension. It is crucial to follow the prescribed dosage and administration guidelines. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

WELIREG 40 mg may interact with certain medications, including those metabolized by the liver's CYP enzymes. Alcohol and other substances that affect liver function should be avoided. Always inform your healthcare provider about all medications you are taking to prevent potential interactions.

Frequently Asked Questions

WELIREG is used to treat specific medical conditions related to abnormal cell growth. It is often prescribed for targeted therapy in certain health issues.

WELIREG is taken orally, typically once daily. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include fatigue, nausea, dizziness, and changes in blood pressure. Consult your healthcare provider if these effects are severe.

It is generally advised to avoid alcohol while taking WELIREG, as it may interact with the medication and affect its effectiveness.

Store WELIREG in a cool, dry place away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.